Bei Akademie registrieren
Dexco, BRDXCOACNOR8

Dexco stock faces BRL 190 million Q3 writedown

Published on 11/09/2026 at 02:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dexco stock faces a major restructuring charge tied to plant and portfolio optimization. Management is shifting capacity toward premium building products.

Dexco Restructures Its Industrial Footprint

  • The third-quarter charge reflects plant, inventory and portfolio adjustments rather than a cash outflow.
  • Dexco has reduced production capacity in sanitary ware and ceramic tiles after closing or selling five factories.
  • Management is shifting toward premium products while targeting lower leverage.
Dexco, BRDXCOACNOR8, Illustration mit AI erstellt.
Dexco, BRDXCOACNOR8, Illustration mit AI erstellt.

Dexco's board approved an estimated BRL 190 million non-recurring EBITDA writedown on October 28, 2026, a charge that will weigh on the third-quarter results without reducing cash. El Fondo reported that the adjustment covers industrial and portfolio optimization.

Non-Cash Charge Hits Third Quarter

The largest portion, BRL 172 million, relates to fixed assets and remaining inventories in the metals and sanitary ware division. A further BRL 8 million is linked to the closure of the Urussanga ceramic tiles plant in Santa Catarina, while BRL 10 million covers net adjustments involving the portfolio and non-operating assets. Dexco said the items would be detailed in the notes to its third-quarter financial statements, released on November 4.

Capacity Cuts Reach Completion

By November 5, Dexco had closed or sold five factories in Brazil over recent years. According to El Fondo, sanitary ware production has been reduced from five plants to one, while ceramic tile manufacturing has been consolidated from three sites to two. Chief Executive Raul Guaragna said no further structural cuts are planned as the group shifts toward premium products.

Losses Contrast With Cash Generation

Dexco reported a BRL 142 million net loss for the third quarter, including BRL 118.4 million in restructuring and plant closure costs and a BRL 20 million credit loss tied to furniture maker Bartira. Net debt ended the quarter at 2.36 times EBITDA, below the company's prior full-year guidance range of 2.5 to 2.7 times. Free cash flow reached about BRL 990 million in the first nine months, giving management room to reduce gross debt and interest costs.

Business Model And Competition

Dexco, headquartered in Sao Paulo, Brazil, operates across wood panels and flooring, sanitary ceramics and metal products under the Deca and Hydra brands, and ceramic tiles under Ceusa and Portinari. Its wood division supplies MDP, MDF and related products to furniture and construction markets. In Brazilian wood panels, it competes with Arauco Brasil and Eucatex, while Fibraplac is another named domestic participant; Dexco is more diversified than these panel-focused rivals because it also operates the Deca and Ceramic Tiles divisions, according to Nexdigm. Global Banking and Finance Review identifies the three operating segments and Dexco's Sao Paulo headquarters.

Dexco Company Facts

  • Company: Dexco S.A.
  • ISIN: BRDXCOACNOR8
  • Ticker: DXCO3
  • Home exchange: B3
  • Sector: Materials
  • Reporting currency: BRL

Brazil's equity market remains the broader backdrop for Dexco investors, with the Bovespa tracking the country's listed shares.

More news and analyses on Dexco stock.

Disclaimer...
en | BRDXCOACNOR8 | DEXCO | boerse | 70478434 |